A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935

Clinical trial NCT02497235 · COMPLETED

Trial details

NCT number: NCT02497235
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents

Start date: 2015-07-01
Primary completion: 2015-12-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.